Jay Batchu
Senior Associate Xontogeny
Jayanth is a Senior Associate at Xontogeny leveraging his diverse skill set to aid the due diligence efforts of the Xontogeny investment team.
Jayanth is experienced in building up multiple biotech and medtech ideas including cell therapies (cancer & autoimmune), engineered enzymes & antibodies, core needle biopsy devices, infectious disease diagnostics, and urinary microvalves. Over the course of advancing prior projects, Jay has been involved with TuckLab and Tuck-Magnuson Startup Incubator and is driven to aid in the advancement of biomedical innovations.
Jayanth received an AB degree in Economics from Dartmouth College, a BE degree in Biomedical Engineering and MEng degree in Biological/Chemical Engineering from Dartmouth’s Thayer School of Engineering. While at Dartmouth, Jay was an active member of the Dartmouth Entrepreneurial Network (DEN) Associates/Magnuson Center Student Leadership Board.
Seminars
- Using a SWOT analysis approach, what are the strengths, weaknesses, opportunities and threats of bispecifics/ multispecifics compared to other drug modalities?
- In which cases are bispecifics/multispecifics being prioritized for autoimmune and immunology versus oncology?
- What datapoints are being assessed when it comes to bispecifics/multispecifics from a data package perspective for approval and backing from pharma?
- What data is lacking across the board for bispecifics/multispecifics?
- How are novel versus derisked targets being assessed, and what weighting/value is placed on safety and efficacy data, versus other data points?
- What stimulates interest around bispecific/multispecific assets versus platform technologies that generate target, construct and format menus?
